Temporary cessation of ibrutinib results in reduced grade 3‐4 infections and durable remissions—Interim analysis of an on‐off‐repeat Phase 1b/2 study in patients with chronic lymphocytic leukemia

Authors: Lundin, Jeanette, Mulder, Tom A., Kättström, Magdalena, Wästerlid, Tove, Uddevik, Anders, Mellstedt, Håkan, Heimersson, Kia, Hansson, Lotta, Palma, Marzia, Österborg, Anders

Source: EJHaem. 2(3):525-529

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100131493881.0x000001&indx=1&recIds=ETOCvdc_100131493881.0x000001

P609: EFFECT OF LONG‐TERM ZANUBRUTINIB TREATMENT ON T‐CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A STUDY CONDUCTED IN PARALLEL WITH THE BGB‐3111‐304 AND 305 TRIALS.

Authors: Andersson, Maria, Aadrian Mulder, Tom, Heimersson, Kia, Sönnert‐Husa, Sonja, Giertz, Annika, Hansson, Lotta, Karlsson, Claes, Lundin, Jeanette, Österborg, Anders, Palma, Marzia

Source: HemaSphere; 2023 Supplement 3, Vol. 7, p1-3, 3p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Expression of the Fractalkine Receptor (CX3CR1) Is Significantly Increased in Immune Cells of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma patients with Active Disease

Authors: Palma, Marzia ^*, Mulder, Tom A. ^*, Heimersson, Kia ^*, Rathje, Li-Sophie ^*, Olin, Thomas ^*, Schultz, Johan ^*, Mellstedt, Håkan ^*, Österborg, Anders

Source: In Blood 13 November 2019 134 Supplement 1:5445-5445

This result is not displayed to guests.
Login for full access.

Reduction of Tumor Burden Rather Than Off-Target Effects Drives Changes in T-Cell Number and Profile during Prolonged Ibrutinib Treatment in Relapsed or Refractory Chronic Lymphocytic Leukemia Patients

Authors: Palma, Marzia ^*, Heimersson, Kia ^*, Mulder, Tom A. ^*, Näsman-Glaser, Barbro ^*, Österborg, Anders, Mellstedt, Håkan ^*

Source: In Blood 29 November 2018 132 Supplement 1:4421-4421

Long-Term Treatment with Ibrutinib in Chronic Lymphocytic Leukemia Patients Normalizes CD3+ and CD8+ T Cells and Immune Checkpoints Expression but Gradually Leads to CD4+ T-Cell Depletion

Authors: Palma, Marzia ^*, Heimersson, Kia ^*, Näsman-Glaser, Barbro ^*, Mellstedt, Håkan ^*, Österborg, Anders

Source: In Blood 8 December 2017 130 Supplement 1:4322-4322

P032: Circulating immune biomarkers in classical Hodgkin lymphoma in relation to tumor burden and response to treatment.

Authors: Mulder, Tom A., Andersson, Maria L., Peña‐Pérez, Lucia, Heimersson, Kia, Xagoraris, Ioanna, Wahlin, Björn E., Månsson, Robert, Hansson, Lotta, Rassidakis, Georgios Z., Palma, Marzia

Source: HemaSphere; 2022 Supplement, Vol. 6, p15-16, 2p

T Cells from Chronic Lymphocytic Leukemia (CLL) Patients Display Dysregulated Expression of Immune Checkpoint Molecules and Activation Markers Mainly Restricted to CD4+ Cells and Correlated with Disease Activity

Authors: Palma, Marzia ^*, Gentilcore, Giusy ^*, Mozaffari, Fariba ^*, Heimersson, Kia ^*, Näsman-Glaser, Barbro ^*, Hansson, Lotta ^*, Österborg, Anders, Mellstedt, Håkan ^*

Source: In Blood 3 December 2015 126(23):4132-4132

Vaccination with Dendritic Cells Loaded with Autologous Leukemic Cells in Combination with Low-Dose Lenalidomide Induced Immune Responses in Chronic Lymphocytic Leukemia (CLL) Patients

Authors: Hansson, Lotta ^*, Palma, Marzia ^*, Adamson, Lars ^*, Ryblom, Harriet ^*, Näsman-Glaser, Barbro ^*, Eriksson, Ingrid ^*, Heimersson, Kia ^*, Gentilcore, Giusy ^*, Mellstedt, Håkan ^*, Österborg, Anders

Source: In Blood 6 December 2014 124(21):4685-4685

Immune Biomarkers in the Peripheral Blood and Tumor Microenvironment of Classical Hodgkin Lymphoma Patients in Relation to Tumor Burden and Response to Treatment.

Authors: Mulder, Tom A., Andersson, Maria L., Peña-Pérez, Lucía, Heimersson, Kia, Xagoraris, Ioanna, Wahlin, Björn E., Månsson, Robert, Hansson, Lotta, Rassidakis, Georgios, Palma, Marzia

Source: HemaSphere; Nov2022, Vol. 6 Issue 11, pe794-e794, 1p

This result is not displayed to guests.
Login for full access.

Long-Term Treatment with Ibrutinib in Chronic Lymphocytic Leukemia Patients Normalizes CD3+and CD8+T Cells and Immune Checkpoints Expression but Gradually Leads to CD4+T-Cell Depletion

Authors: Palma, Marzia, Heimersson, Kia, Näsman-Glaser, Barbro, Mellstedt, Håkan, Österborg, Anders

Source: Blood; December 2017, Vol. 130 Issue: 1, Number 1 Supplement 1 p4322-4322, 1p

T Cells from Chronic Lymphocytic Leukemia (CLL) Patients Display Dysregulated Expression of Immune Checkpoint Molecules and Activation Markers Mainly Restricted to CD4+Cells and Correlated with Disease Activity

Authors: Palma, Marzia, Gentilcore, Giusy, Mozaffari, Fariba, Heimersson, Kia, Näsman-Glaser, Barbro, Hansson, Lotta, Österborg, Anders, Mellstedt, Håkan

Source: Blood; December 2015, Vol. 126 Issue: 23 p4132-4132, 1p